Gossamer Bio Analyst Price Targets

Wall Street analyst price targets and consensus rating for Gossamer Bio (GOSS).

Price Target Range — 12 Quarters

Analyst Consensus — 10 Analysts

7Buy

2Hold

1Sell

Consensus RatingBuy# Analysts10Avg. Consensus PT$376Upside to Avg. PT+3987.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 26, 2026	Chardan Capital	Andreas Argyrides	Maintained	Buy	$160
Oct 15, 2026	Chardan Capital	Andreas Argyrides	Maintained	Buy	$160
Oct 13, 2026	Chardan Capital	Andreas Argyrides	Initiate	Buy	$160
Sep 21, 2026	HC Wainwright & Co.	Patrick R. Trucchio	PT Raise	Buy	$2→$90
Aug 14, 2026	Piper Sandler	Yasmeen Rahimi	PT Cut	Overweight	$1200→$320
Jul 28, 2026	Leerink Partners	Joseph Schwartz	Upgrade	Market Perform→Outperform	$80
Jul 27, 2026	HC Wainwright & Co.	Patrick R. Trucchio	Maintained	Buy	$160
Jun 25, 2026	HC Wainwright & Co.	Patrick R. Trucchio	PT Cut	Buy	$400→$160
May 26, 2026	HC Wainwright & Co.	Patrick R. Trucchio	Maintained	Buy	$400
May 19, 2026	Barclays	Eliana Merle	PT Cut	Underweight	$24→$22
Mar 23, 2026	Cantor Fitzgerald	Olivia Brayer	Downgrade	Overweight→Neutral	—
Mar 6, 2026	HC Wainwright & Co.	Patrick R. Trucchio	PT Cut	Buy	$800→$400
Mar 5, 2026	Oppenheimer	Andreas Argyrides	PT Cut	Outperform	$960→$240
Feb 24, 2026	Wedbush	Laura Chico	Downgrade	Outperform→Neutral	$480→$80
Feb 24, 2026	Barclays	Eliana Merle	Downgrade	Overweight→Underweight	$720→$24
Feb 24, 2026	Leerink Partners	Joseph Schwartz	Downgrade	Outperform→Market Perform	$480→$80
Jan 28, 2026	Barclays	Eliana Merle	Initiate	Overweight	$720
Jan 22, 2026	HC Wainwright & Co.	Patrick R. Trucchio	Maintained	Buy	$800
Sep 11, 2025	Cantor Fitzgerald	Olivia Brayer	Maintained	Overweight	—
Sep 10, 2025	UBS	Eliana Merle	Upgrade	Neutral→Buy	$100→$720

Analyst Ratings News

PRO
Chardan Capital Initiates Coverage On Gossamer Bio with Buy Rating, Announces Price Target of $160

Chardan Capital analyst Andreas Argyrides initiates coverage on Gossamer Bio (NASDAQ:GOSS) with a Buy rating and announces Price Target of $160.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Gossamer Bio, Raises Price Target to $90

HC Wainwright & Co. analyst Patrick R. Trucchio maintains Gossamer Bio (NASDAQ:GOSS) with a Buy and raises the price target from $2 to $90.

Benzinga Newsdesk

PRO
Piper Sandler Maintains Overweight on Gossamer Bio, Lowers Price Target to $4

Piper Sandler analyst Yasmeen Rahimi maintains Gossamer Bio (NASDAQ:GOSS) with a Overweight and lowers the price target from $15 to $4.

Benzinga Newsdesk

This Crowdstrike Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Top Wall Street analysts changed outlook on top names. See all rating changes on analyst ratings page. Analysts have positive views on FTH stock.

Avi Kapoor

This Honeywell Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday

Top Wall Street analysts upgraded Grupo Cibest, Lufax, Honeywell, and Gossamer Bio. JBS also received an upgrade. See what analysts think.

Avi Kapoor

PRO
Leerink Partners Upgrades Gossamer Bio to Outperform, Maintains Price Target to $1

Leerink Partners analyst Joseph Schwartz upgrades Gossamer Bio (NASDAQ:GOSS) from Market Perform to Outperform and maintains the price target from $1 to $1.

Benzinga Newsdesk

Gossamer Bio Inc

Gossamer Bio Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Chardan Capital Initiates Coverage On Gossamer Bio with Buy Rating, Announces Price Target of $160

PRO
HC Wainwright & Co. Maintains Buy on Gossamer Bio, Raises Price Target to $90

PRO
Piper Sandler Maintains Overweight on Gossamer Bio, Lowers Price Target to $4

This Crowdstrike Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

This Honeywell Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday

PRO
Leerink Partners Upgrades Gossamer Bio to Outperform, Maintains Price Target to $1

People Also Watch

People Also Watch

Gossamer Bio Inc

Gossamer Bio Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROChardan Capital Initiates Coverage On Gossamer Bio with Buy Rating, Announces Price Target of $160

PROHC Wainwright & Co. Maintains Buy on Gossamer Bio, Raises Price Target to $90

PROPiper Sandler Maintains Overweight on Gossamer Bio, Lowers Price Target to $4

This Crowdstrike Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

This Honeywell Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday

PROLeerink Partners Upgrades Gossamer Bio to Outperform, Maintains Price Target to $1

People Also Watch

People Also Watch

PRO
Chardan Capital Initiates Coverage On Gossamer Bio with Buy Rating, Announces Price Target of $160

PRO
HC Wainwright & Co. Maintains Buy on Gossamer Bio, Raises Price Target to $90

PRO
Piper Sandler Maintains Overweight on Gossamer Bio, Lowers Price Target to $4

PRO
Leerink Partners Upgrades Gossamer Bio to Outperform, Maintains Price Target to $1